Tag: Infection Prevention

ECRI issues statement on COVID-19 vaccine boosters, global vaccine equity

Editor's Note In an October 26 news release, ECRI announced the publication of a Position Statement on “COVID-19 Vaccines: Mitigating Disease and Promoting Global Health Equity.” Speaking in support of the Statement, Marcus Schabacker, MD, PhD, president and chief executive officer, ECRI, says: “Despite the FDA and CDC’s advancement of…

Read More

By: Judy Mathias
October 27, 2021
Share

Association of allergy history with allergic reactions in HCWs after COVID-19 vaccinations

Editor's Note This study by researchers at Harvard Medical School, Brigham and Women’s Hospital, and Massachusetts General Hospital, Boston, finds that a high-risk allergy history was associated with a 2.5-fold higher risk of allergic reactions after mRNA COVID-19 vaccinations. However, most of the allergy symptoms did not hold up completion…

Read More

By: Judy Mathias
October 26, 2021
Share

CDC expands eligibility for COVID-19 boosters

Editor's Note The Centers for Disease Control and Prevention (CDC) director Rochelle P. Walensky, MD, MPH, on October 21, endorsed the CDC Advisory Committee on Immunization Practices’ recommendation for a booster of COVID-19 vaccines in certain populations. For individuals who received Pfizer-BioNTech or Moderna COVID-19 vaccines, the following are eligible…

Read More

By: Judy Mathias
October 26, 2021
Share

COVID-19 breakthrough infections in HCWs vaccinated with the Pfizer-BioNTech vaccine

  Editor's Note This Israeli study finds that in healthcare workers (HCWs) vaccinated with the Pfizer-BioNTech vaccine who had breakthrough infections, the suspected source was an unvaccinated person. Among 11,453 fully vaccinated HCWs, 1,497 had RT-PCR testing during the study period. Of the tested HCWs, 39 breakthrough cases were found.…

Read More

By: Judy Mathias
October 25, 2021
Share

COVID-19 vaccine acceptance, access among Blacks, Latinxs

Editor's Note This study by researchers at Yale University School of Medicine, New Haven, Connecticut, identifies three themes centered on trust and addressing barriers to COVID-19 vaccine access in Black and Latinx communities in the US. The study involved 72 participants—56 women, 16 men, 36 Black, 28 Latinx, and 8…

Read More

By: Judy Mathias
October 14, 2021
Share

Survey: COVID-19 seropositivity among high-risk HCWs

Editor's Note This survey of high-risk healthcare workers (HCWs) at Sharp HealthCare in San Diego County finds a relatively small proportion who were seropositive for COVID-19. Of 1,770 participants, 39 (2.2%) had a positive antibody test. Among 22 who reported a history of presumptive or confirmed COVID-19, 14 were antibody…

Read More

By: Judy Mathias
October 12, 2021
Share

Back table UV light decreases environmental contamination

Editor's Note In this study, researchers from Colorado Joint Replacement, Denver, find that a back table ultraviolet light (UV) decreases environmental contamination near the operative field, which may lead to a decrease in joint infections. Either a back table germicidal UV light-emitting diode or a sham device was used during…

Read More

By: Judy Mathias
October 7, 2021
Share

Association of physical activity, screen time with children’s mental health during COVID-19

Editor's Note This study from the Seattle Children’s Research Institute and University of Washington finds that more physical activity and less screen time were associated with better mental health for children during the COVID-19 pandemic. A survey was conducted from October 22 to November 2, 2020, of 547 parents of…

Read More

By: Judy Mathias
October 5, 2021
Share

Occupational exposures, secondary cases of COVID-19 in HCWs

Editor's Note In this study, researchers from Northwestern Memorial Hospital and Feinberg School of Medicine, Chicago, find that more healthcare workers (HCWs) were exposed to COVID-19 by coworkers than patients, and lapses in infection prevention practices increased transmission risk. Between June and December 2020, 2,357 HCWs were involved in occupational…

Read More

By: Judy Mathias
October 4, 2021
Share

CDC: Safety monitoring of COVID-19 vaccine booster dose

Editor's Note This study by researchers at the Centers for Disease Control and Prevention finds that adverse reactions after the third dose of Pfizer-BioNTech’s COVID-19 vaccine were similar to those after the second dose. Of 12,591 participants who completed a survey after all three doses: 79.4% and 74.1% reported local…

Read More

By: Judy Mathias
October 1, 2021
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat